About the Oncodermatologists Session
Oncodermatologists diagnose and manage skin conditions related to cancer, including skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma. They evaluate patients undergoing cancer treatments like chemotherapy and radiation, addressing side effects such as rashes, dryness, and nail changes. Identifying early signs of skin malignancies and precancerous lesions plays a crucial role in improving patient outcomes. Treatment plans may include surgical procedures, targeted therapies, and topical or systemic medications to manage cancer-related skin issues.
Dermatologists, and other specialists ensures comprehensive care for individuals affected by cancer. Monitoring skin reactions to cancer treatments helps in adjusting therapies for better tolerance and quality of life. Prevention strategies, including patient education on sun protection and regular skin screenings, contribute to early detection and risk reduction. Research and advancements in dermatologic oncology support the development of innovative treatment approaches, improving care for patients with cancer-associated skin conditions. Many cancer therapies, including chemotherapy, targeted therapies, immunotherapies, and radiation, can cause severe skin-related side effects such as rashes, radiation dermatitis, hand-foot syndrome, skin infections, pigment changes, hair and nail abnormalities, and chronic ulcers. These adverse effects not only impact a patient’s quality of life but can also lead to treatment delays or discontinuation. Oncodermatologists help mitigate these issues by providing specialized skincare regimens, prescribing anti-inflammatory medications, and using laser treatments to reduce discomfort and skin damage.
Featured Speakers — Oncodermatologists 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Oncodermatologists Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Oncodermatologists Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Oncodermatologists work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Oncodermatologists research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same programme, same certificate.
Join IDC 2027 for the Oncodermatologists track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Oncodermatologists Conference 2027 — FAQs
What is the Oncodermatologists track at IDC 2027?
The Oncodermatologists track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Oncodermatologists. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Oncodermatologists sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Oncodermatologists are all welcome — whether presenting or attending.
Can I present my research in the Oncodermatologists track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Oncodermatologists sessions?
Yes. IDC 2027 is a hybrid conference — attend the Oncodermatologists track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

